MktsMarkets

Zymeworks Inc.
NASDAQ: ZYMEKey statistics
ZYME News
Stories mentioning ZYME from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 2,408 | 2,515 | 27,614 | 48,726 | 27,110 | 31,031 | 16,000 | 19,243 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (47,118) | (44,152) | (22,110) | (674.00) | (25,613) | (22,217) | (34,205) | (42,886) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (18.00) | 26.00 | (8.00) | 51.00 | (253.00) | (37.00) | 53.00 | |
| Pretax Income | (46,353) | (41,479) | (18,266) | 2,131 | (22,140) | (17,791) | (29,624) | (37,618) |
| Tax Provision | (2,191) | (270.00) | 1,336 | (186.00) | 496.00 | 5,715 | 226.00 | 68.00 |
| Net Income (Loss) | (44,162) | (41,209) | (19,602) | 2,317 | (22,636) | (23,506) | (29,850) | (37,686) |
| Earnings Per Share (Basic) | (0.59) | (0.55) | (0.26) | 0.03 | (0.30) | (0.31) | (0.39) | (0.49) |
| Earnings Per Share (Diluted) | (0.59) | (0.55) | (0.26) | 0.03 | (0.30) | (0.31) | (0.39) | (0.49) |
| Weighted Average Shares Outstanding (Basic) | 74,669 | 75,405 | 75,768 | 75,337 | 75,171 | 75,847 | 76,129 | 76,393 |
| Weighted Average Shares Outstanding (Diluted) | 74,695 | 75,413 | 75,775 | 77,378 | 75,226 | 75,879 | 76,157 | 76,396 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ZYME
Zymeworks Inc. (NASDAQ: ZYME) is a stock listed on the Nasdaq Stock Market under the ticker symbol ZYME. It last traded at $25.54 (Oct 19, 2026, 4:00 PM ET), up 2.0% on the day. That gives Zymeworks a market capitalisation of $2.0B.
Over the past 52 weeks ZYME has traded between $16.00 and $31.34.
Revenue for the quarter ended Mar 31, 2026 was $2.4M; a net loss of $44.2M. Revenue was down 91.1% from $27.1M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $2.4M | -$44.2M | -1834.0% |
| Dec 31, 2025 | $2.5M | -$41.2M | -1638.5% |
| Sep 30, 2025 | $27.6M | -$19.6M | -71.0% |
| Jun 30, 2025 | $48.7M | $2.3M | 4.8% |
From Zymeworks’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…